Abstract :
In a trial that involved over 1,500 patients at seven hospitals, the device correctly identified 91 percent of the people who had a candida infection. This led to the U.S. Food and Drug Administration???s taking just three months???record time for a new technology???to approve T2???s instrument and candida test.
